BridgeMD
New treatment option for Non-suicidal Self-injury
Official title Effects of taVNS Combined With tACS on Adolescents With Non-Suicidal Self-Injury
ClinicalTrials.gov ID: NCT07486804
What this study is testing
- What it's testing
- NSSI behavior is highly prevalent among adolescents, and its mechanisms are closely associated with attentional bias toward self-injury-related information and impulsivity, both of which may be related to reduced dlPFC activation levels. Introducing taVNS as a priming stimulus to pre-regulate brain state and optimize subsequent tACS treatment response provides a novel approach to addressing inconsistent intervention effects.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 12 to 22
You may be able to join if
- Meet the proposed diagnostic criteria for non-suicidal self-injury (NSSI) in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition...
- Aged 12-18 years
- Right-handed
- Possess formal education experience sufficient to comprehend experimental protocols
- Normal or corrected-to-normal binocular visual acuity
You likely can't join if
- Montreal Cognitive Assessment (MoCA) score \< 26
- History of suicide attempts
- History of epilepsy, brain surgery, tumors, or clinically significant head trauma
- History of substance abuse or severe physical diseases
- Received physical or psychological interventions within the past three months
See the full eligibility criteria
- Meet the proposed diagnostic criteria for non-suicidal self-injury (NSSI) in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), with ≥5 documented self-injury episodes and at least one...
- Aged 12-18 years
- Right-handed
- Possess formal education experience sufficient to comprehend experimental protocols
- Normal or corrected-to-normal binocular visual acuity
- Voluntarily participate with legal guardians providing written informed consent
- Montreal Cognitive Assessment (MoCA) score \< 26
- History of suicide attempts
- History of epilepsy, brain surgery, tumors, or clinically significant head trauma
- History of substance abuse or severe physical diseases
- Received physical or psychological interventions within the past three months
The study team makes the final eligibility decision.
Where it's taking place
- Hefei, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 12 years to 22 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Hefei, Anhui, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.